comparemela.com

Page 4 - Shikma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hikma appoints Riad Mishlawi as CEO

Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

LONDON (dpa-AFX) - Shares of Hikma Pharmaceuticals PLC (HIK, HIK.L) were gaining around 4 percent in the early morning trading in London after the company on Thursday said it is confident of fiscal

Junshi Bioscience and Hikma expand cancer treatment to Middle East and North Africa

Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle East and North Africa region

Hikma Pharma Says Outlook For All Divisions Intact

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK) Thursday said its full-year outlook for all of its three segments including Injectables, Branded, and Generics remain unchanged. 'We are seeing

Hikma Pharmaceuticals Reports Lower H1 Profit; Sets Interim Dividend

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK) on Thursday reported profit before tax of $215 million for the first half, lower than $319 million in the year-ago period.Excluding one-time items

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.